Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,009 across all filing types
Latest filing 2022-11-02 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于控股股东的一致行动人部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a controlling shareholder and their concerted parties. It details the number of shares released from pledge, the proportion of shares pledged, and related shareholder information. There is no financial data, earnings information, or management discussion. The content focuses on share pledge status and shareholder disclosures. This fits the category of a Major Shareholding Notification or related shareholder pledge updates. Given the specific focus on shareholding and pledge changes, the best fitting category is Major Shareholding Notification (MRQ). The document length is short and it is not a report or announcement of a report publication, so RPA is not appropriate.
2022-11-02 Chinese
关于控股股东及其一致行动人持股比例变动超过1%的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a change in shareholding by the controlling shareholder and their concerted parties, specifically a reduction in shareholding exceeding 1%. It details the number of shares reduced, the percentage of total share capital, the method of transaction (block trade), and confirms compliance with relevant securities laws. There is no financial statement, management discussion, or report content. The document is a notification of a major shareholding change, fitting the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, confirming it is not a full report or other type of filing.
2022-11-01 Chinese
关于独立董事取得独立董事资格证书的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding an independent director obtaining the required qualification certificate. It mentions the election of an independent director at a shareholders' meeting and the subsequent receipt of the independent director qualification certificate as per Shenzhen Stock Exchange regulations. There is no financial data, no report attached or referenced, and no mention of management changes beyond the qualification status. This fits best under Board/Management Information (MANG) as it relates to board member qualifications and status updates.
2022-11-01 Chinese
关于控股股东部分股份质押展期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the extension of a pledge on shares held by the controlling shareholder. It details the number of shares pledged, the proportion of shares pledged relative to total holdings and company stock, and the pledge expiration dates. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledge extension, which fits best under the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Capital/Financing Update (CAP) because it explicitly states no new financing is involved, nor is it a share issue or buyback. The document length is short (1135 characters), and it is a formal disclosure of share pledge status and extension, typical of regulatory filings in the Chinese market.
2022-11-01 Chinese
董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from the company Chengdu Berry Genomics Co., Ltd. It specifically mentions the approval of the '2022 Third Quarter Report' by the board of directors. The document is short (687 characters) and primarily announces the board's approval and the intention to publish the quarterly report elsewhere. It does not contain the actual financial statements or substantive financial data of the quarterly report itself. Therefore, this document is an announcement related to the interim/quarterly report rather than the report itself. According to the rules, such announcements are best classified as Regulatory Filings (RNS) because it does not contain the full report or detailed financial data, and it is not merely a publication announcement (RPA) since it includes the board resolution details.
2022-10-28 Chinese
监事会决议公告
Report Publication Announcement Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2022 third quarter report. It states that the Supervisory Board has reviewed and approved the 2022 third quarter report, confirming its compliance with legal and regulatory requirements. The document itself does not contain the full financial report but announces the approval and publication of the quarterly report. The length is short (688 characters), and it mentions that the report will be published on various platforms. According to the 'Menu vs Meal' rule, this is an announcement of the report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2022-10-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.